Dimensional Fund Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.57M Buy
487,647
+21,765
+5% +$204K ﹤0.01% 2548
2025
Q1
$5.72M Buy
465,882
+134,582
+41% +$1.65M ﹤0.01% 2460
2024
Q4
$4.38M Buy
331,300
+283,577
+594% +$3.75M ﹤0.01% 2576
2024
Q3
$919K Sell
47,723
-22,458
-32% -$432K ﹤0.01% 2926
2024
Q2
$1.44M Sell
70,181
-38,464
-35% -$790K ﹤0.01% 2843
2024
Q1
$2.59M Sell
108,645
-658
-0.6% -$15.7K ﹤0.01% 2733
2023
Q4
$2.36M Buy
109,303
+3,163
+3% +$68.4K ﹤0.01% 2758
2023
Q3
$1.54M Sell
106,140
-488,322
-82% -$7.09M ﹤0.01% 2839
2023
Q2
$12.4M Sell
594,462
-725,763
-55% -$15.2M ﹤0.01% 2159
2023
Q1
$27.9M Buy
1,320,225
+54,096
+4% +$1.14M 0.01% 1734
2022
Q4
$32.2K Buy
1,266,129
+143,677
+13% +$3.66K 0.01% 1606
2022
Q3
$27M Buy
1,122,452
+161,346
+17% +$3.88M 0.01% 1651
2022
Q2
$18.5M Buy
961,106
+76,772
+9% +$1.48M 0.01% 1907
2022
Q1
$15.4M Buy
884,334
+90,634
+11% +$1.58M ﹤0.01% 2110
2021
Q4
$17.4M Buy
793,700
+145,674
+22% +$3.19M 0.01% 2061
2021
Q3
$12.4M Buy
648,026
+146,228
+29% +$2.79M ﹤0.01% 2230
2021
Q2
$8.62M Sell
501,798
-207,841
-29% -$3.57M ﹤0.01% 2432
2021
Q1
$15.8M Sell
709,639
-66,069
-9% -$1.47M 0.01% 2117
2020
Q4
$17.3M Sell
775,708
-78,260
-9% -$1.74M 0.01% 2050
2020
Q3
$12.6M Sell
853,968
-29,268
-3% -$432K 0.01% 2085
2020
Q2
$13.1M Sell
883,236
-5,280
-0.6% -$78.2K 0.01% 2092
2020
Q1
$9.75M Sell
888,516
-49,445
-5% -$542K 0.01% 2133
2019
Q4
$8.24M Sell
937,961
-18,979
-2% -$167K ﹤0.01% 2426
2019
Q3
$7.15M Buy
956,940
+12,490
+1% +$93.3K ﹤0.01% 2476
2019
Q2
$8.79M Buy
944,450
+36,597
+4% +$341K ﹤0.01% 2440
2019
Q1
$4.77M Buy
907,853
+97,669
+12% +$513K ﹤0.01% 2664
2018
Q4
$3.61M Buy
810,184
+14,417
+2% +$64.2K ﹤0.01% 2701
2018
Q3
$6.43M Buy
795,767
+237,042
+42% +$1.91M ﹤0.01% 2607
2018
Q2
$3.92M Buy
558,725
+161,146
+41% +$1.13M ﹤0.01% 2726
2018
Q1
$5.66M Buy
397,579
+173,821
+78% +$2.47M ﹤0.01% 2590
2017
Q4
$1.96M Buy
223,758
+168,478
+305% +$1.48M ﹤0.01% 2860
2017
Q3
$647K Buy
55,280
+41,537
+302% +$486K ﹤0.01% 3070
2017
Q2
$192K Buy
+13,743
New +$192K ﹤0.01% 3203